DJIA 17,195.42 221.11 1.30%
NASDAQ 4,566.14 16.91 0.37%
S&P 500 1,994.65 12.35 0.62%
market minute promo

56.47 1.98 (3.63%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

TEVA $56.47 3.63%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $53.92
Previous Close $54.49
Daily Range $53.89 - $56.70
52-Week Range $36.26 - $56.70
Market Cap $48.2B
P/E Ratio 36.57
Dividend (Yield) $1.20 (2.1%)
Ex-Dividend Date
Dividend Pay Date
08/19/14
09/04/14
Volume 8,363,467
Average Daily Volume 3,886,203
Current FY EPS $4.97

Sector

Healthcare

Industry

Drugs

Teva Pharmaceutical Industries (TEVA) Description

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories. Website: http://www.tevapharm.com/

News & Commentary Rss Feed

Is Mylan's Lively Third Quarter the Start of Something Special?

Mylan posts Street-beating top and bottom lines behind strong growth in Q3 -- and successfully completing its agreement to purchase a portion of Abbott Labs' generics business could lead to more success ahead.

Teva Pharmaceutical Industries' (TEVA) CEO Erez Vigodman on Q3 2014 Results - Earnings Call Transcri

Teva Pharmaceutical Industries' (TEVA) CEO Erez Vigodman on Q3 2014 Results - Earnings Call Transcript

Teva Pharmaceutical Industries (TEVA) Down In Pre-Market Trading

UPDATE: Teva Posts Stronger-Than-Expected Q3 Profit, Lifts Forecast

Will Teva (TEVA) Beat Q3 Earnings on Strong Generic Sales? - Analyst Blog

Will AbbVie (ABBV) Disappoint in this Earnings Season? - Analyst Blog

BioTime: Recent News Hints At Positive Developments

Will Aegerion (AEGR) Disappoint This Earnings Season? - Analyst Blog

Will Aegerion (AEGR) Disappoint This Earnings Season? - Analyst Blog

Will Novartis (NVS) Disappoint in Q3 Earnings Season? - Analyst Blog

Lannett Co. Gets Growth Rx In Generic Drugs Group

See More TEVA News...

TEVA's Top Competitors

TEVA $56.47 (3.63%)
Current stock: TEVA
NVS $91.95 (0.70%)
Current stock: NVS
PFE $29.84 (1.19%)
Current stock: PFE
JNJ $107.04 (1.40%)
Current stock: JNJ